Avax S.a.ATHEX: AVAX

Interim Financial Report 30.06.2025

· MarketScreener
AVAX S.A. Interim Condensed Financial Statements for the period January 1stto June 30th, 2025 AVAX S.A.

Company's Number in the General Electronic Commercial Registry

:913601000 (former Company's Number in the Register of Societes

Anonymes: 14303/06/B/86/26)

16 Amaroussiou-Halandriou str.,151-25, Marousi, Greece

INDEX OF INTERIM CONDENSED FINANCIAL STATEMENTS

2

Website where the company's and consolidated financial statements are available

5

I) Statements of members of the board of directors

6

II) Report of the board of directors

7

A. Main Business Segment Activity

7

B. Financial Results for the First Half of 2025

7

C. Risks related to Non-Financial Matters

20

D. Policies and Codes of AVAX, the parent Company of the Group

24

III) Independent auditor's review report

32

IV) Interim Condensed Financial Statements period from January 1st, 2025 to June 30th, 2025

33

- Interim Condensed Statement of Financial Position

33

- Interim Condensed Statement of Income

34

- Interim Condensed Statement of Comprehensive Income

35

- Interim Condensed Statement of Cash Flow

36

- Interim Condensed Statement of Changes in Equity

37

V) Notes and accounting policies

39

Α. INFORMATION ABOUT THE COMPANY

39

Α.1 General Information about the Company and the Group

39

Α2. Activities

39

Β. FINANCIAL REPORTING STANDARDS

40

Β.1. Compliance with IFRS

40

Β.2. Basis of preparation of the financial statements

40

C. BASIC ACCOUNTING PRINCIPLES

40

C.1. Consolidated finacial statements (IFRS 10) & Business Combinations (I.F.R.S. 3)

40

C.2a. Property, Plant & Equipment (I.A.S. 16)

46

C.2b. Investment Property (IAS 40)

47

C.3. Intangible Assets (I.A.S. 38)

47

C.4. Impairment of Assets (I.A.S. 36)

47

C.5. Inventories (I.A.S. 2)

48

C.6. Financial Instruments: Presentation (IAS 32)

48

C.7. Financial Instruments: Disclosures (IFRS 7)

49

2

C.8. Provisions, Contingent Liabilities and Contingent Assets (I.A.S. 37)

49



C.9. The effects of changes in Foreign Exchange Rates (I.A.S. 21)

49

C.10. Earnings per share (I.A.S. 33)

49

C.11. Dividend Distribution (I.A.S. 10)

49

C.12. Income Taxes & Deferred Tax (I.A.S. 12)

49

C.13. Personnel Benefits (I.A.S. 19)

50

C.14. Leases (I.F.R.S. 16)

51

C.15. Borrowing Cost (I.A.S. 23)

52

C.16. Operating Segments (I.F.R.S. 8)

52

C.17. Related Party Disclosures (I.A.S. 24)

52

C.18. Revenue from contracts with customers (I.F.R.S. 15)

53

C.19. Financial Instruments (I.F.R.S. 9)

54

C.20. Restricted cash deposits

56

C.21. Non-current assets held for sale & discontinued operations (I.F.R.S. 5)

56

C.22. Significant accounting estimates and judgments

57

C.22.1 Impairment of goodwill

57

C.22.2 Income taxes

57

C.22.3 Deferred tax assets

57

C.22.4 Asset lives and residual values

57

C.22.5 Allowance for net realizable value of inventory

58

C.22.6 Allowance for doubtful accounts receivable

58

C.22.7 Provision for staff leaving indemnities

58

C.22.8 Contingent liabilities

58

C.22.9 Revenue from Contracts with Customers (I.F.R.S. 15)

58

C.22.10 Joint Arrangements (I.F.R.S. 11)

58

C.22.11 Fair Value measurement (I.F.R.S. 13)

58

D. NEW STANDARDS, INTERPRETATIONS AND AMENDMENT OF CURRENT STANDARDS

58

E. NOTES TO THE FINANCIAL STATEMENTS

62

1a. Primary reporting format - business segments

62

1b. Secondary reporting format - Geographical segments

65

1c. Information about key customers (>=10%)

67

3



2. Property, Plant and Equipment

68

2a. Right of Use assets

69

3. Investment Property

70

4. Intangible Assets

71

5. Investments in Subsidiaries/Associates and other companies

72

5a. Financial assets at fair value through other comprehensive income

72

6. Trade and other receivables

72

6a. Other Debtors / Ongoing litigations

72

7. Cash and cash equivalent

73

7a. Restricted Cash Deposits

73

8. Trade and other payables

73

8a. Contractual assets/liabilities

73

9. Borrowings

74

9a. Liabilities from financing Leases (IFRS 16)

74

10. Change in financial activity

75

11. Other provisions and non-current liabilities

76

12. Income and other tax liabilities

76

13. Share Capital

77

14. Other Reserves

77

15. Revaluation Reserves for Financial Assets at fair value

77

16. Reserves from foreign profits Law 4171/61

77

17. Reserves art 48 L.4172/2013

78

18. Memorandum accounts - Contingent liabilities

78

19. Encumbrances - Concessions of Receivables

78

20. Number of employees

78

21. Contingent Receivables and Liabilities

78

22. Transactions with related parties

79

23. Fair Value measurement

83

24. Risk Management

84

25. Important Events during the First Half of 2025 & their Impact on Financial Results

86

26. Important Post Balance Sheet Date Developments & Events

88

4

27. Approval of Financial Statements

89

INTERIM CONDENSED FINANCIAL REPORTING FOR THE PERIOD JANUARY 1stTO JUNE 30th2025 WEBSITE WHERE THE COMPANY'S AND CONSOLIDATED FINANCIAL STATEMENTS ARE AVAILABLE

We hereby certify that the attached Interim Financial Statements, which are an integral part of the semi-annual financial report of article 5 of Law 3556/2007, are those approved by the Board of Directors of "AVAX SA" on 24.09.2025 and have been published by posting them on the internet, at (https://www.avax.gr), as well as on the Athens Stock Exchange web site, where they will remain at the disposal of the investing public for at least ten (10) years from the date of their compilation and disclosure. The Annual Financial Statements of the Group's subsidiaries are also published at https://www.avax.gr.

It is noted that the disclosed condensed financial statements and information resulting from the interim six-month condensed financial statements are intended to provide the reader with a general overview of the Company's and the Group's financial position and results but do not provide a comprehensive view of the financial position, the Company's and the Group's financial performance and cash flows, in accordance with International Financial Reporting Standards.

5

Earlier from Avax

All Avax news releases